Get the Stockscreener App
5.32
1.72%
0.09
Optimizerx Corp stock is traded at $5.32, with a volume of 198.17K.
It is up +1.72% in the last 24 hours and up +2.11% over the past month.
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
See More
Previous Close:
$5.23
Open:
$5.24
24h Volume:
198.17K
Relative Volume:
0.42
Market Cap:
$99.83M
Revenue:
$107.35M
Net Income/Loss:
$6.84M
P/E Ratio:
15.06
EPS:
0.3532
Net Cash Flow:
$14.64M
1W Performance:
+5.35%
1M Performance:
+2.11%
6M Performance:
-59.64%
1Y Performance:
-62.72%
1-Day Range:
$5.2235
$5.415
1-Week Range:
$4.922
$5.415
52-Week Range:
$4.57
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
Name
Optimizerx Corp
Sector
Industry
Phone
248-651-6558
Address
260 CHARLES STREET, WALTHAM, MI
Compare OPRX vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
5.32 | 98.14M | 107.35M | 6.84M | 14.64M | 0.3532 |
VEEV
Veeva Systems Inc
|
162.17 | 26.34B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
64.08 | 12.41B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
52.32 | 8.59B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
86.97 | 7.39B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
68.35 | 5.06B | 646.34M | -512.40M | 202.76M | -6.6871 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Feb-02-23 | Resumed | B. Riley Securities | Buy |
| Nov-01-22 | Initiated | Stifel | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| Oct-18-21 | Resumed | B. Riley Securities | Buy |
| Apr-13-21 | Initiated | RBC Capital Mkts | Outperform |
| Jan-03-19 | Initiated | William Blair | Outperform |
View All
Optimizerx Corp Stock (OPRX) Latest News
OptimizeRx (NASDAQ: OPRX) holders add 1M plan shares, reject evergreen - Stock Titan
OptimizeRx Secures $35 Million Senior Credit Facility to Fuel Growth - citybuzz -
ContactThe Lethbridge HeraldNews and Sports from around Lethbridge - FinancialContent
OPRX SEC FilingsOptimizerx Corp 10-K, 10-Q, 8-K Forms - Stock Titan
OptimizeRx: A Good Business That Has Not Yet Earned Back Investor Trust - Investing.com
OptimizeRx (OPRX) grants 34,517 restricted stock units to director - Stock Titan
[Form 4] OptimizeRx Corp Insider Trading Activity - Stock Titan
OptimizeRx Corp stock: Q1 earnings beat lifted shares - AD HOC NEWS
OptimizeRx Corp. Sees Valuation Upgrade Amid Positive Financial Trends and High Institutional Confidence - MarketsMojo
OptimizeRx parts ways with Theresa Greco; will serve as advisor through June 15, 2027 - TradingView
OptimizeRx (NASDAQ: OPRX) details CCO exit, $380K salary continuation - Stock Titan
OptimizeRx Corporation Announces Resignation of Theresa Greco as Chief Commercial Officer Role, Effective June 15, 2026 - marketscreener.com
OPRX Technical Analysis | Trend, Signals & Chart Patterns | OPTIMIZERX CORP (NASDAQ:OPRX) - ChartMill
OptimizeRx to Participate in Upcoming Investor Conferences - The Globe and Mail
Where to meet OptimizeRx: investor 1x1s in Boston and Chicago - Stock Titan
OPRX Q1 2026 Earnings: EPS Surges 4017% Above Estimates Amid Strong ExecutionEPS Estimate Trend - The Legal Advocate
OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet? - TradingView
DeepIntent Expands Healthcare DSP With EHR Integration - MarTech Cube
OptimizeRx Q1 earnings call highlights - MSN
OptimizeRx Corp. and DeepIntent Announce First Integration of EHR Network into Healthcare Advertising Platform - Quiver Quantitative
DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network - The Manila Times
Drug ads move into doctors' EHR screens in OptimizeRx–DeepIntent pact - Stock Titan
OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds - qz.com
OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold? - sharewise.com
OptimizeRx Corp stock (US6837631027): earnings momentum and buyback plan put focus back on digital h - AD HOC NEWS
OptimizeRx (OPRX) CCO logs Form 4 tax-withholding share dispositions - Stock Titan
OptimizeRx (OPRX) CEO has 5,219 shares withheld to cover RSU tax - Stock Titan
OptimizeRx's Q4 Beat: A Closer Look at the Numbers - Kavout
OptimizeRx (OPRX) Q1 2026 Earnings Transcript - AOL.com
OptimizeRx Corp stock (US6837631027): earnings beat, buyback plan and volatile AI-health rally - AD HOC NEWS
OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead? - Yahoo Finance
Some OptimizeRx Corporation (NASDAQ:OPRX) Analysts Just Made A Major Cut To Next Year's Estimates - Yahoo Finance
OptimizeRx Corp stock (US6837631027): Bank note points to valuation reset - AD HOC NEWS
OptimizeRx Secures New Credit Facility to Boost Flexibility - The Globe and Mail
OptimizeRx Expands EHR Advertising Reach With New DSP Integration - qz.com
OptimizeRx (NASDAQ: OPRX) cuts Q1 loss as margins improve and debt refinanced - Stock Titan
Stifel cuts OptimizeRx stock price target on weaker guidance - Investing.com UK
B. Riley Adjusts Price Target on OptimizeRx to $10 From $11, Maintains Buy Rating - marketscreener.com
Stifel cuts OptimizeRx stock price target on weaker guidance By Investing.com - Investing.com Australia
OptimizeRx Corporation (NASDAQ:OPRX) Q1 2026 Earnings Call Transcript - Insider Monkey
OPRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance - The Manila Times
Earnings call transcript: OptimizeRx Q1 2026 beats estimates, stock rises - Investing.com UK
OptimizeRx Exceeds Expectations with Strong Q1 Growth - Intellectia AI
OptimizeRx Q1 Earnings Call Highlights - sharewise.com
Earnings Call Summary | OptimizeRx(OPRX.US) Q1 2026 Earnings Conference - Moomoo
OptimizeRx Corp. (OPRX) surpasses Q1 earnings and revenue estimates - MSN
Optimizerx Corp Stock (OPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
3.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):